UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mukoviszidose – wenn die Diagnose unsicher bleibt

Zeitschrift für Pneumologie, 2024-11, Vol.21 (6), p.357-365

2024

Volltextzugriff (PDF)

182 Lung clearance index to detect the efficacy of aztreonam lysine inhalation in CF patients with near normal spirometry – an observational proof-of-concept study

Journal of cystic fibrosis, 2017-06, Vol.16, p.S113-S113

2017

Volltextzugriff (PDF)

395 Challenges in implementing Mental Health Screening (MHS) – a single centre experience

Journal of cystic fibrosis, 2017-06, Vol.16, p.S162-S163

2017

Volltextzugriff (PDF)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis

Pulmonary Medicine, 2014-01, Vol.2014 (2014), p.67-88

2014

Volltextzugriff (PDF)

397 The course of anxiety and depression in adult CF patients – preliminary results of a two-year experience with Mental Health Screening (MHS)

Journal of cystic fibrosis, 2017-06, Vol.16, p.S163-S163

2017

Volltextzugriff (PDF)

WS17.4 Fecal calprotectin and its relation to disease parameters – a longitudinal analysis over 12 years

Journal of cystic fibrosis, 2016-06, Vol.15, p.S28-S29

2016

Volltextzugriff (PDF)

288 Resilience, intolerance of uncertainty, and CF patients’ quality of life

Journal of cystic fibrosis, 2015-06, Vol.14, p.S131-S131

2015

Volltextzugriff (PDF)

WS09.4 The role of resilience in quality of life of adult patients with cystic fibrosis (CF)

Journal of cystic fibrosis, 2015-06, Vol.14, p.S17-S17

2015

Volltextzugriff (PDF)

Mukoviszidose – wenn die Diagnose unsicher bleibt

Monatsschrift Kinderheilkunde, 2024, Vol.172 (6), p.510-518

2024

Volltextzugriff (PDF)

CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa

Pneumologie (Stuttgart, Germany), 2018-05, Vol.72 (5), p.347

2018

Volltextzugriff (PDF)

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings

The Journal of clinical investigation, 2001-12, Vol.108 (11), p.1705-1715

2001

Volltextzugriff (PDF)

WS17.05 Significant reduction of systemic inflammatory markers in patients with cystic fibrosis with triple therapy lasts for at least 2 years

Journal of cystic fibrosis, 2024-06, Vol.23, p.S32-S33

2024

Volltextzugriff (PDF)

298 Delivery of CF care through the patients' eyes: Repeated surveys of patients' experiences at Innsbruck CF centre

Journal of cystic fibrosis, 2013-06, Vol.12, p.S124-S124

2013

Volltextzugriff (PDF)

Intraosseous lines in preterm and full term neonates

Archives of disease in childhood. Fetal and neonatal edition, 1999-01, Vol.80 (1), p.F74-F75

1999

Volltextzugriff (PDF)

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”

Pulmonary medicine, 2015, Vol.2015 (2015), p.1-2

2015

Volltextzugriff (PDF)

311 Do quality of life responses signal severe loss of lung function?

Journal of cystic fibrosis, 2013-06, Vol.12, p.S128-S128

2013

Volltextzugriff (PDF)

312 The course of perceived treatment burden in adolescent and adult CF patients

Journal of cystic fibrosis, 2012-06, Vol.11, p.S136-S136

2012

Volltextzugriff (PDF)

WS11.3 Predicting anxiety, depression and affectivity in adults living with cystic fibrosis: the role of psychological resilience and self-compassion over a 2-year period

Journal of cystic fibrosis, 2021, Vol.20, p.S21

2021

Volltextzugriff (PDF)

EPS2.07 The Brief Resilience Scale (BRS) as a possible routine assessment instrument for patients with cystic fibrosis: predictive power in psychological symptoms and quality of life

Journal of cystic fibrosis, 2023-06, Vol.22, p.S41-S42

2023

Volltextzugriff (PDF)

EPS2.05 Arm circumference and skinfolds vs. body mass index: a single-centre experience over two decades

Journal of cystic fibrosis, 2021, Vol.20, p.S33

2021

Volltextzugriff (PDF)

EPS6.09 Mid-term effect of elexacaftor/tezacaftor/ivacaftor on lung function in people with cystic fibrosis: real-world data of the German cystic fibrosis registry

Journal of cystic fibrosis, 2023-06, Vol.22, p.S55-S55

2023

Volltextzugriff (PDF)

EPS9.02 Pseudomonas aeruginosa in sputum cultures of patients with cystic fibrosis before and during one year of elexacaftor/tezacaftor/ivacaftor

Journal of cystic fibrosis, 2023-06, Vol.22, p.S61-S61

2023

Volltextzugriff (PDF)

P193 Cytokine values in nasal lavage samples of patients with cystic fibrosis indicate a primary mucosal immune response in patients with mild lung disease

Journal of cystic fibrosis, 2024-06, Vol.23, p.S115-S115

2024

Volltextzugriff (PDF)

IPD2.04 Long-term effects of ivacaftor in patients with G551D mutation and mild lung disease

Journal of cystic fibrosis, 2018-06, Vol.17, p.S54-S54

2018

Volltextzugriff (PDF)

ePS4.04 Skinfold measurements for nutritional assessment: a longitudinal single centre analysis

Journal of cystic fibrosis, 2020-06, Vol.19, p.S47-S47

2020

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(79)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Male
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Female
(21)
Child
(17)
Adult
(15)
Pulmonary/respiratory
(15)
Pediatrics
(14)
Adolescent
(13)
Child, Preschool
(12)
Cystic Fibrosis
(11)
Infant
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(7)
Infant, Newborn
(7)
Other Diseases. Semiology
(6)
Austria
(5)
Cystic Fibrosis - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mukoviszidose – wenn die Diagnose unsicher bleibt

182 Lung clearance index to detect the efficacy of aztreonam lysine inhalation in CF patients with near normal spirometry – an observational proof-of-concept study

395 Challenges in implementing Mental Health Screening (MHS) – a single centre experience

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis

397 The course of anxiety and depression in adult CF patients – preliminary results of a two-year experience with Mental Health Screening (MHS)

WS17.4 Fecal calprotectin and its relation to disease parameters – a longitudinal analysis over 12 years

288 Resilience, intolerance of uncertainty, and CF patients’ quality of life

WS09.4 The role of resilience in quality of life of adult patients with cystic fibrosis (CF)

Mukoviszidose – wenn die Diagnose unsicher bleibt

CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings

WS17.05 Significant reduction of systemic inflammatory markers in patients with cystic fibrosis with triple therapy lasts for at least 2 years

298 Delivery of CF care through the patients' eyes: Repeated surveys of patients' experiences at Innsbruck CF centre

Intraosseous lines in preterm and full term neonates

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”

311 Do quality of life responses signal severe loss of lung function?

312 The course of perceived treatment burden in adolescent and adult CF patients

WS11.3 Predicting anxiety, depression and affectivity in adults living with cystic fibrosis: the role of psychological resilience and self-compassion over a 2-year period

EPS2.07 The Brief Resilience Scale (BRS) as a possible routine assessment instrument for patients with cystic fibrosis: predictive power in psychological symptoms and quality of life

EPS2.05 Arm circumference and skinfolds vs. body mass index: a single-centre experience over two decades

EPS6.09 Mid-term effect of elexacaftor/tezacaftor/ivacaftor on lung function in people with cystic fibrosis: real-world data of the German cystic fibrosis registry

EPS9.02 Pseudomonas aeruginosa in sputum cultures of patients with cystic fibrosis before and during one year of elexacaftor/tezacaftor/ivacaftor

P193 Cytokine values in nasal lavage samples of patients with cystic fibrosis indicate a primary mucosal immune response in patients with mild lung disease

IPD2.04 Long-term effects of ivacaftor in patients with G551D mutation and mild lung disease

ePS4.04 Skinfold measurements for nutritional assessment: a longitudinal single centre analysis

Suchergebnisse filtern